Abstract
Multiple myeloma (MM) is a cancerous bone disease characterized by malignant transformation of plasma cells in the bone marrow. MM is considered to be the second most common blood malignancy, with 20,000 new cases reported every year in the USA. Extensive research is currently enduring to validate diagnostic and therapeutic means to manage MM. microRNAs (miRNAs) were shown to be dysregulated in MM cases and to have a potential role in either progression or suppression of MM. Therefore, researchers investigated miRNAs levels in MM plasma cells and created tools to test their impact on tumor growth. In the present review, we discuss the most recently discovered miRNAs and their regulation in MM. Furthermore, we emphasized utilizing miRNAs as potential targets in the diagnosis, prognosis and treatment of MM, which can be useful for future clinical management.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference190 articles.
1. Smoldering multiple myeloma: Pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies;Kazandjian;Clin. Adv. Hematol. Oncol.,2014
2. Non Secretory Multiple Myeloma with Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma
3. IgD-kappa multiple myeloma. Case report and brief review of the literature;Bakheet;N. Z. J. Med. Lab. Sci.,2016
4. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
5. A monoclonal gammopathy precedes multiple myeloma in most patients
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献